TECTONIC THERAPEUTIC, INC. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
TECTONIC THERAPEUTIC, INC. (TECX) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $67.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2022-11-08
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2021-09-30 was $0.00.
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2021-06-30 was $67.00K.
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2020-03-31 was $419.00K.
- TECTONIC THERAPEUTIC, INC. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2018-09-30 was $168.00K.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 6 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $67.00K derived: sum of 2 quarters · filed 2022-11-08 | $67.00K 10-Q · filed 2022-11-08 |
| 2021-06-30 | $67.00K 10-Q · filed 2022-08-09 | $67.00K 10-Q · filed 2022-08-09 | |
| 2020-03-31 | $419.00K 10-Q · filed 2021-05-13 | ||
| 2018-09-30 | $168.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |